A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Vertex Pharmaceuticals (VRTX) has seen its share price under pressure recently, with a 1 day return of a 1.0% decline and a 7 day return of a 3.0% decline, putting recent trading firmly in focus for investors. See our latest analysis for Vertex Pharmaceuticals. The 90 day share price return of 10.2% decline and 1 year total shareholder return of 14.2% decline suggest momentum has cooled recently. However, the 3 year and 5 year total shareholder returns of 23.5% and 95.5% still reflect a much stronger longer term picture. If you are comparing Vertex with other opportunities in high growth areas, this is a good moment to scan the market using our curated list of 32 healthcare AI stocks So with recent share price weakness, alongside revenue of US$12.0b, net income of US$4.0b, and a value score of 4, is Vertex trading at a discount, or is the market already pricing in its future growth? Most Popular Narrative: 22.2% Undervalued At a last close of $426.01 against a narrative f
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight [Yahoo! Finance]Yahoo! Finance
- 3 Market-Beating Stocks to Consider Right Now [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (VRTX) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial [MSNBC.com]MSNBC.com
- Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 4/29/26 - Form DEFA14A
- 4/29/26 - Form 8-K
- 4/17/26 - Form 4
- VRTX's page on the SEC website